$PMDI
PSYCHEMEDICS CORP Stock $pmdi

$pmdi Overview Financials Valuation SEC Filings Company Website

2013 Form 10-K Financial Statement

#000114420414012603 Filed on February 28, 2014

Income Statement

Concept	2013	2012 Q4	2012 Q3
Revenue	$26.87M	$5.658M	$6.460M
YoY Change	6.53%	1.95%	2.22%
Cost Of Revenue	$11.48M	$2.890M	$2.742M
YoY Change	4.6%	21.94%	15.7%
Gross Profit	$15.39M	$2.766M	$3.718M
YoY Change	8.02%	-12.74%	-5.63%
Gross Profit Margin	57.29%	48.89%	57.55%
Selling, General & Admin	$8.863M	$2.160M	$1.990M
YoY Change	4.38%	-2.7%	-0.52%
% of Gross Profit	57.57%	78.09%	53.51%
Research & Development	$825.1K	$150.0K	$297.1K
YoY Change	-0.05%	-28.57%	112.21%
% of Gross Profit	5.36%	5.42%	7.99%
Depreciation & Amortization	$872.2K	$170.0K	$140.0K
YoY Change	48.59%	54.55%	55.56%
% of Gross Profit	5.67%	6.15%	3.77%
Operating Expenses	$9.688M	$2.300M	$2.287M
YoY Change	3.99%	-5.35%	6.86%
Operating Profit	$5.706M	$464.0K	$1.431M
YoY Change	15.61%	-37.3%	-20.5%
Interest Expense	$90.00K	$0.00	$0.00
YoY Change
% of Operating Profit	1.58%	0.0%	0.0%
Other Income/Expense, Net	$92.27K
YoY Change	4784.75%
Pretax Income	$5.799M	$460.0K	$1.431M
YoY Change	17.44%	-38.67%	-20.92%
Income Tax	$1.993M	$190.0K	$552.9K
% Of Pretax Income	34.38%	41.3%	38.63%
Net Earnings	$3.805M	$273.0K	$879.0K
YoY Change	27.71%	-37.95%	-20.09%
Net Earnings / Revenue	14.16%	4.83%	13.61%
Basic Earnings Per Share	$0.72	$0.05	$0.17
Diluted Earnings Per Share	$0.72	$0.05	$0.17
COMMON SHARES
Basic Shares Outstanding	5.299M shares		5.272M shares
Diluted Shares Outstanding	5.315M shares		5.290M shares

Balance Sheet

Concept	2013	2012 Q4	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.970M	$3.070M	$3.660M
YoY Change	29.32%	-44.78%	4.57%
Cash & Equivalents	$3.970M	$3.066M	$3.663M
Short-Term Investments		$0.00
Other Short-Term Assets	$1.060M	$1.030M	$1.540M
YoY Change	2.91%	15.73%	28.33%
Inventory
Prepaid Expenses
Receivables	$4.370M	$4.621M	$5.340M
Other Receivables	$550.0K	$850.0K	$0.00
Total Short-Term Assets	$9.960M	$9.574M	$10.55M
YoY Change	4.08%	-16.75%	-3.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.050M	$4.201M	$3.490M
YoY Change	44.05%	103.95%	101.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$50.00K	$345.3K	$310.0K
YoY Change	0.0%	43.87%	40.91%
Total Long-Term Assets	$6.590M	$4.547M	$3.800M
YoY Change	44.84%	97.68%	94.87%
TOTAL ASSETS
Total Short-Term Assets	$9.960M	$9.574M	$10.55M
Total Long-Term Assets	$6.590M	$4.547M	$3.800M
Total Assets	$16.55M	$14.12M	$14.35M
YoY Change	17.21%	2.32%	11.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$510.0K	$669.8K	$1.270M
YoY Change	-23.88%	-30.23%	337.93%
Accrued Expenses	$2.450M	$1.414M	$980.0K
YoY Change	88.46%	7.09%	-31.94%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.960M	$2.083M	$2.250M
YoY Change	42.31%	-8.63%	30.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.960M	$2.083M	$2.250M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$4.270M	$2.898M	$2.730M
YoY Change	47.24%	4.62%	57.8%
SHAREHOLDERS EQUITY
Retained Earnings		-$7.186M
YoY Change
Common Stock		$28.49M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)		$10.08M
YoY Change
Treasury Stock Shares		668.1K shares
Shareholders Equity	$12.28M	$11.22M	$11.62M
YoY Change
Total Liabilities & Shareholders Equity	$16.55M	$14.12M	$14.35M
YoY Change	17.21%	2.32%	11.67%

Cashflow Statement

Concept	2013	2012 Q4	2012 Q3
OPERATING ACTIVITIES
Net Income	$3.805M	$273.0K	$879.0K
YoY Change	27.71%	-37.95%	-20.09%
Depreciation, Depletion And Amortization	$872.2K	$170.0K	$140.0K
YoY Change	48.59%	54.55%	55.56%
Cash From Operating Activities	$5.950M	$610.0K	$1.030M
YoY Change	92.56%	-80.7%	-1571.43%
INVESTING ACTIVITIES
Capital Expenditures	$1.532M	-$370.0K	-$1.290M
YoY Change	-30.82%	-17.78%	258.33%
Acquisitions
YoY Change
Other Investing Activities	-$230.0K	-$40.00K	-$40.00K
YoY Change	91.67%	300.0%	-102.03%
Cash From Investing Activities	-$1.760M	-$420.0K	-$1.330M
YoY Change	-24.79%	-8.7%	-182.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.290M	-790.0K	-790.0K
YoY Change	1.23%	25.4%	21.54%
NET CHANGE
Cash From Operating Activities	5.950M	610.0K	1.030M
Cash From Investing Activities	-1.760M	-420.0K	-1.330M
Cash From Financing Activities	-3.290M	-790.0K	-790.0K
Net Change In Cash	900.0K	-600.0K	-1.090M
YoY Change	-136.0%	-128.99%	-222.47%
FREE CASH FLOW
Cash From Operating Activities	$5.950M	$610.0K	$1.030M
Capital Expenditures	$1.532M	-$370.0K	-$1.290M
Free Cash Flow	$4.418M	$980.0K	$2.320M
YoY Change	404.41%	-72.85%	700.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	58994	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	823274	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	769269	USD
CY2012Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	854212	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	209877	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	292795	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	9573916	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	9956268	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2083330	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2958470	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	90746	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	10568	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	0	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4368864	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	0	USD
CY2010Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	289371	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	221239	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	199838	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2011	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	14988	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	68132	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	21401	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	7900	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	176950	shares
CY2010Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.96
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.62
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.62
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.58
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	15.06
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.61
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.75
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.04
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y2M12D
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	115135	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3065785	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3970512	USD
CY2013Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	554828	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4201409	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6050203	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	345293	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	543345	USD
CY2012Q4	us-gaap	Assets Assets	14120618	USD
CY2013Q4	us-gaap	Assets Assets	16549816	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	669789	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	510550	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1413541	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2447920	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	814619	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1314221	USD
CY2012Q4	us-gaap	Liabilities Liabilities	2897949	USD
CY2013Q4	us-gaap	Liabilities Liabilities	4272691	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	29703	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	29910	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	28460764	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	28888712	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7186009	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6559708	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10081789	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10081789	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	11222669	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	12277125	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14120618	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16549816	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	121583	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	144921	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	872521	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	872521	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5940558	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5981896	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	668130	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	668130	shares
CY2012	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	25223534	USD
CY2013	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	26870297	USD
CY2011	us-gaap	Cost Of Services CostOfServices	9616985	USD
CY2012	us-gaap	Cost Of Services CostOfServices	10971886	USD
CY2013	us-gaap	Cost Of Services CostOfServices	11476263	USD
CY2011	us-gaap	Gross Profit GrossProfit	14472623	USD
CY2012	us-gaap	Gross Profit GrossProfit	14251648	USD
CY2013	us-gaap	Gross Profit GrossProfit	15394034	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3948706	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3946844	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4157597	USD
CY2011	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4116059	USD
CY2012	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4543598	USD
CY2013	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4704970	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	607408	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	825518	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	825102	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	8672173	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	9315960	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	9687669	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	5800450	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	4935688	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	5706365	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	5346	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	1889	USD
CY2013	us-gaap	Investment Income Interest InvestmentIncomeInterest	92273	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5805796	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4937577	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5798638	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2316513	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1957948	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1993428	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	3489283	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	2979629	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	3805210	USD
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.67
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.57
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	0	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3720488	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5564233	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	-2401957	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	-1715000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	-1233000	USD
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
CY2011	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.48
CY2012	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.60
CY2013	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.60
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5229646	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5260320	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5299060	shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5235940	shares
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5272542	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5315463	shares
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	370020	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	586968	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	872171	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	418077	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	458167	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	538304	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	585155	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	129792	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-251904	USD
CY2011	pmd	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	428769	USD
CY2012	pmd	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	547895	USD
CY2013	pmd	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	-353389	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	262011	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-292055	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-159239	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	19486	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-406011	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-126876	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	406853	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	437720	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	416684	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3935201	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3086731	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	5951547	USD
CY2012	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	121375	USD
CY2013	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	226130	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	528788	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2335423	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1757762	USD
CY2011	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	22391	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2011	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2510861	USD
CY2012	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3156592	USD
CY2013	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3178909	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-2620244	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-3249756	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-3289058	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1843745	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2498448	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	904727	USD
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Trading Symbol TradingSymbol	PMD
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5320355	shares
CY2013	dei	Entity Registrant Name EntityRegistrantName	PSYCHEMEDICS CORP
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0000806517
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	dei	Entity Public Float EntityPublicFloat	44000000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4620768	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Estimates</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 15pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates, including those related to bad debts and income tax valuation, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2011	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	86992	USD
CY2012Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1210734	USD
CY2013Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1958780	USD
CY2012Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	659866	USD
CY2013Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	779891	USD
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	92371	USD
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	439414	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4395605	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5175722	USD
CY2012Q4	pmd	Laboratory Equipment LaboratoryEquipment	6634043	USD
CY2013Q4	pmd	Laboratory Equipment LaboratoryEquipment	8047840	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8597014	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11225925	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	6244000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	6432000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	6862000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	6899000	USD
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	6460000	USD
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	7055000	USD
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	5658000	USD
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	6484000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	3665000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	3487000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	4103000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	4079000	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	3718000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	4176000	USD
CY2012Q4	us-gaap	Gross Profit GrossProfit	2766000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	3652000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1377000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1202000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1664000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1732000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1431000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1739000	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	464000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	1033000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	827000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	822000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	1001000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	1063000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	879000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	1052000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	273000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	868000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2011	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	122961	USD
CY2012	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	147360	USD
CY2013	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	141661	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-16605	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	609000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	550000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	25000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1184000	USD
CY2011	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2018452	USD
CY2012	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
CY2013	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
CY2011	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	548000	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	555000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	605000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1358790	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2214048	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1531632	USD
CY2011	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	131	USD
CY2012	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	185	USD
CY2013	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	185	USD
CY2011	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2012	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2013	us-gaap	Stock Issued1 StockIssued1	20817	USD
CY2011	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2012	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	497696	USD
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1161255	USD
CY2011	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	6294	shares
CY2012	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	12222	shares
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	16403	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5272428	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5313766	shares
CY2011	us-gaap	Depreciation And Amortization DepreciationAndAmortization	362282	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	573712	USD
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	844093	USD
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	264088	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	191597	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	152650	shares
CY2011	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	86992	USD
CY2012	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	93164	USD
CY2013	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	110149	USD
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	169191	USD
CY2012	pmd	Provision For Recoveries Of Doubtful Accounts ProvisionForRecoveriesOfDoubtfulAccounts	28866	USD
CY2013	pmd	Provision For Recoveries Of Doubtful Accounts ProvisionForRecoveriesOfDoubtfulAccounts	-82332	USD
CY2012	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	18742	USD
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.344	pure
CY2011	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	36143	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	20839	USD
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2012Q4	pmd	Accrued Building Maintenance AccruedBuildingMaintenance	63785	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.056	pure
CY2012	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	93164	USD
CY2013	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	154522	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.055	pure
CY2012Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	360702	USD
CY2013Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	185937	USD
CY2012Q4	pmd	Accrued Hair Collection Expense AccruedHairCollectionExpense	113355	USD
CY2013Q4	pmd	Accrued Hair Collection Expense AccruedHairCollectionExpense	119587	USD
CY2012Q4	pmd	Accrued Audit And Tax Consulting AccruedAuditAndTaxConsulting	110491	USD
CY2013Q4	pmd	Accrued Audit And Tax Consulting AccruedAuditAndTaxConsulting	144018	USD
CY2012Q4	pmd	Accrued Payable For Equipment Purchases AccruedPayableForEquipmentPurchases	497696	USD
CY2013Q4	pmd	Accrued Payable For Equipment Purchases AccruedPayableForEquipmentPurchases	1161255	USD
CY2012Q4	pmd	Other Accrued Expenses OtherAccruedExpenses	57809	USD
CY2013Q4	pmd	Other Accrued Expenses OtherAccruedExpenses	176003	USD
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.011	pure
CY2011	pmd	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.001	pure
CY2012	pmd	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.001	pure
CY2013	pmd	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.007	pure
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1450941	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1196926	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1499400	USD
CY2011	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	458719	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	323302	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	77344	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1909660	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1520228	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1576744	USD
CY2011	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	370710	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	346974	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	406116	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	418077	USD
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.002	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0	pure
CY2012	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	458167	USD
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.399	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.396	pure
CY2013	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	538304	USD
CY2011	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	22391	USD
CY2011	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2510861	USD
CY2012	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3156592	USD
CY2013	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3178909	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	9747513	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	11034629	USD
CY2013	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	23534	USD
CY2013Q4	pmd	Accrued Building Maintenance AccruedBuildingMaintenance	142340	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	162792	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	160850	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	47959	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	48578	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	55401	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	83367	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	56275	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	0	USD
CY2012Q4	pmd	Deferred Tax Liabilities Excess Of Tax Over Book Depreciation And Amortization DeferredTaxLiabilitiesExcessOfTaxOverBookDepreciationAndAmortization	814619	USD
CY2013Q4	pmd	Deferred Tax Liabilities Excess Of Tax Over Book Depreciation And Amortization DeferredTaxLiabilitiesExcessOfTaxOverBookDepreciationAndAmortization	1314221	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-604742	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-1021426	USD
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2012Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	870894	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1314221	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	266152	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	292795	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	pmd	Accrued Bonus Expense AccruedBonusExpense	90000	USD
CY2013Q4	pmd	Accrued Bonus Expense AccruedBonusExpense	251700	USD
CY2012Q4	pmd	Accrued Vacation Expense AccruedVacationExpense	119703	USD
CY2013Q4	pmd	Accrued Vacation Expense AccruedVacationExpense	267080	USD
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	53636	USD

Files In Submission

Name	View Source	Status
0001144204-14-012603-index-headers.html	Edgar Link	pending
0001144204-14-012603-index.html	Edgar Link	pending
0001144204-14-012603.txt	Edgar Link	pending
0001144204-14-012603-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ft0001img-1.jpg	Edgar Link	pending
pmd-20131231.xml	Edgar Link	completed
pmd-20131231.xsd	Edgar Link	pending
pmd-20131231_cal.xml	Edgar Link	unprocessable
pmd-20131231_def.xml	Edgar Link	unprocessable
pmd-20131231_lab.xml	Edgar Link	unprocessable
pmd-20131231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v368759_10k.htm	Edgar Link	pending
v368759_ex23-1.htm	Edgar Link	pending
v368759_ex31-1.htm	Edgar Link	pending
v368759_ex31-2.htm	Edgar Link	pending
v368759_ex32-1.htm	Edgar Link	pending
v368759_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMDI
PSYCHEMEDICS CORP Stock $pmdi

2013 Form 10-K Financial Statement

#000114420414012603 Filed on February 28, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI PSYCHEMEDICS CORP Stock $pmdi

2013 Form 10-K Financial Statement

#000114420414012603 Filed on February 28, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI
PSYCHEMEDICS CORP Stock $pmdi